Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

604-who-recist-and-immune-related-response-criteria-is-it-time-to-revisit-pembrolizumab-results

Short Communication: WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results

Felipe Ades, Nise Yamaguchi

3 Dec 2015

https://doi.org/10.3332/ecancer.2015.604

Abstract | Full Article | PDF

566-diagnostic-value-of-sox-10-immunohistochemical-staining-for-the-detection-of-uveal-melanoma

Research: Diagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma

Sarah A Alghamdi, Pablo Zoroquiain, Ana Beatriz T Dias, Sulaiman R Alhumaid, Sultan Aldrees, Miguel N Burnier Jr

20 Aug 2015

https://doi.org/10.3332/ecancer.2015.566

Abstract | Full Article | PDF

526-the-role-of-human-papillomaviruses-in-carcinogenesis

Special Issue: The role of human papillomaviruses in carcinogenesis

Raffaella Ghittoni, Rosita Accardi, Susanna Chiocca, Massimo Tommasino

29 Apr 2015

https://doi.org/10.3332/ecancer.2015.526

Abstract | Full Article | PDF | Spanish

519-report-on-the-oeci-eacr-precision-medicine-for-cancer-conference-1-4-march-2015-luxembourg

Conference Report: Report on the OECI-EACR Precision Medicine for Cancer conference, 1-4 March 2015, Luxembourg

Anna Golebiewska, Sabrina Fritah, Maria Romina Girotti

3 Apr 2015

https://doi.org/10.3332/ecancer.2015.519

Abstract | Full Article | PDF

513-repurposing-drugs-in-oncology-redo-clarithromycin-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent

An MT Van Nuffel, Vidula Sukhatme, Pan Pantziarka, Lydie Meheus, Vikas P Sukhatme, Gauthier Bouche

24 Feb 2015

https://doi.org/10.3332/ecancer.2015.513

Abstract | Full Article | PDF

511-report-from-the-second-mib-melanoma-independent-board-conference-27-28-october-2014

Conference Report: Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014

Alessandro Testori, Carlo Riccardo Rossi, Paolo Ascierto, Francesco De Lorenzo, Nicola Mozzillo

19 Feb 2015

https://doi.org/10.3332/ecancer.2015.511

Abstract | Full Article | PDF

485-repurposing-drugs-in-oncology-redo-cimetidine-as-an-anti-cancer-agent

Clinical Study: Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent

Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P Sukhatme

26 Nov 2014

https://doi.org/10.3332/ecancer.2014.485

Abstract | Full Article | PDF

472-from-precision-medicine-to-cancer-care-through-the-immunome-highlights-from-the-european-society-of-medical-oncology-congress-madrid-26-30th-september-2014

Conference Report: From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26–30th September 2014

Giuseppe Curigliano

16 Oct 2014

https://doi.org/10.3332/ecancer.2014.472

Abstract | Full Article | PDF

444-a-golden-anniversary-highlights-of-the-50th-annual-meeting-of-the-american-society-of-clinical-oncology

Conference Report: A golden anniversary: highlights of the 50th annual meeting of the American Society of Clinical Oncology

Gordon McVie, Audrey Nailor

10 Jul 2014

https://doi.org/10.3332/ecancer.2014.444

Abstract | Full Article | PDF

440-report-from-the-melanoma-independent-board-first-melanoma-mib-conference-21-22-october-2013

Conference Report: Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013

A Testori, P Ascierto, V Chiarion Sileni, F De Lorenzo, PG Pelicci, CR Rossi

30 Jun 2014

https://doi.org/10.3332/ecancer.2014.440

Abstract | Full Article | PDF

More from ecancer